Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bos

Showing results (211-220 of 491) with videos related to

Pageof 50
Sort By:
Plos One|September 27, 2024
Proteomic analysis of dorsal root ganglia in a mouse model of paclitaxel-induced neuropathic painRania Hanna, Alexandru Graur, Patricia Sinclair, et al.
Experimental Dermatology|August 1, 1993
Review of the etiopathomechanism of vitiligo: a convergence theoryI C Le Poole, P K Das, R M van den Wijngaard, et al.
Immunology|October 1, 1989
The selective antigen-presenting cell capacity of activated B lymphocytes in HLA-II-restricted responses of CD4+ T lymphocytesT T Van Der Pouw Kraan, F E Stiekema, M B Teunissen, et al.
Intensive Care Medicine Experimental|September 18, 2015
Tumor necrosis factor receptor 1 (TNFRI) for ventilator-associated pneumonia diagnosis by cytokine multiplex analysisIgnacio Martin-Loeches, Lieuwe D Bos, Pedro Povoa, et al.
Archives of Dermatological Research|January 1, 1994
Reappraisal of in situ immunophenotypic analysis of psoriasis skin: interaction of activated HLA-DR+ immunocompetent cells and endothelial cells is a major feature of psoriatic lesionsO J de Boer, C M van der Loos, F Hamerlinck, et al.
The British Journal of Dermatology|August 1, 1994
Morphoea lesions are associated with aberrant expression of membrane cofactor protein and decay accelerating factor in vascular endotheliumG T Venneker, P K Das, B Naafs, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 1, 1994
Aberrant expression of membrane cofactor protein and decay-accelerating factor in the endothelium of patients with systemic sclerosis. A possible mechanism of vascular damageG T Venneker, F H van den Hoogen, A M Boerbooms, et al.
The British Journal of Dermatology|July 7, 2011
Teledermatology applied following patient selection by general practitioners in daily practice improves efficiency and quality of care at lower costJ P van der Heijden, N F de Keizer, J D Bos, et al.
The British Journal of Dermatology|March 25, 2010
Is there a rural/urban gradient in the prevalence of eczema? A systematic reviewM E Schram, A M Tedja, R Spijker, et al.
FEMS Immunology and Medical Microbiology|August 6, 1999
Serum neopterin as a marker for reactional states in leprosyF F Hamerlinck, P R Klatser, D S Walsh, et al.
Pageof 50

Showing results (211-220 of 491) with videos related to

Sort By:
Pageof 50
Plos One|September 27, 2024
Proteomic analysis of dorsal root ganglia in a mouse model of paclitaxel-induced neuropathic painRania Hanna, Alexandru Graur, Patricia Sinclair, et al.
Experimental Dermatology|August 1, 1993
Review of the etiopathomechanism of vitiligo: a convergence theoryI C Le Poole, P K Das, R M van den Wijngaard, et al.
Immunology|October 1, 1989
The selective antigen-presenting cell capacity of activated B lymphocytes in HLA-II-restricted responses of CD4+ T lymphocytesT T Van Der Pouw Kraan, F E Stiekema, M B Teunissen, et al.
Intensive Care Medicine Experimental|September 18, 2015
Tumor necrosis factor receptor 1 (TNFRI) for ventilator-associated pneumonia diagnosis by cytokine multiplex analysisIgnacio Martin-Loeches, Lieuwe D Bos, Pedro Povoa, et al.
Archives of Dermatological Research|January 1, 1994
Reappraisal of in situ immunophenotypic analysis of psoriasis skin: interaction of activated HLA-DR+ immunocompetent cells and endothelial cells is a major feature of psoriatic lesionsO J de Boer, C M van der Loos, F Hamerlinck, et al.
The British Journal of Dermatology|August 1, 1994
Morphoea lesions are associated with aberrant expression of membrane cofactor protein and decay accelerating factor in vascular endotheliumG T Venneker, P K Das, B Naafs, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 1, 1994
Aberrant expression of membrane cofactor protein and decay-accelerating factor in the endothelium of patients with systemic sclerosis. A possible mechanism of vascular damageG T Venneker, F H van den Hoogen, A M Boerbooms, et al.
The British Journal of Dermatology|July 7, 2011
Teledermatology applied following patient selection by general practitioners in daily practice improves efficiency and quality of care at lower costJ P van der Heijden, N F de Keizer, J D Bos, et al.
The British Journal of Dermatology|March 25, 2010
Is there a rural/urban gradient in the prevalence of eczema? A systematic reviewM E Schram, A M Tedja, R Spijker, et al.
FEMS Immunology and Medical Microbiology|August 6, 1999
Serum neopterin as a marker for reactional states in leprosyF F Hamerlinck, P R Klatser, D S Walsh, et al.
Pageof 50